News | April 06, 2010

TomoTherapy Delivers High Conformality in Arc-Based IMRT

April 6, 2010 - Helical TomoTherapy delivers continuous arc-based intensity-modulated radiation therapy (IMRT) that gives high conformality and excellent dose homogeneity for the target volume, concluded a study published online March issue of the Internal Journal of Radiation Oncology Biology Physics.

The study, entitled “Standard and Nonstandard Craniospinal Radiotherapy Using Helical TomoTherapy, conducted at McGill University Health Centre, applied helical TomoTherapy technology in a variety of cases requiring craniospinal irradiation (CSI) in children and young adults.

Researchers focused on four patients, three of whom had complicating circumstances, such as unusual anatomy, prior radiation treatment or multiple boost targets. The first was a standard case of CSI in a 19-year-old patient with recurrent myxopapillary ependymoma (MPE). Two other patients received non-standard CSI via differential dosing. One of them was a seven-year-old with recurrent medulloblastoma who had been treated before and required a simultaneous dose reduction to the posterior fossa, and the other was a 14-year-old with metastatic tumors throughout the craniospinal axis from MPE who required concurrent boosting of multiple sites. The fourth patient was a 21-year-old with neurofibromatosis and pronounced scoliosis who needed treatment of the whole spine for recurrent MPE.

Clinicians were able to extend the length of the radiation fields up to 60 cm to 90 cm with TomoTherapy technology, compared to field lengths of up to only 40 cm for standard radiation therapy solutions. This capability of the TomoTherapy system to create long fields means the entire craniospinal axis can be treated with a single set-up, thereby “obviating the risks associated with use of abutting fields, junctions and beam gaps,” as the study reported. In addition, accurate patient setup via integrated MVCT imaging enables a margin reduction, which enables sparing of more healthy tissue.

All patients in the study received treatment while lying on their back, with a standard thermoplastic mask used for immobilization. Beam-on time ranged from 10-15.7 minutes and total time on the treatment table was typically 45 minutes for adult patients and 30 minutes for children. This is similar to, or less than, conventional treatment times.

The researchers concluded: "Helical TomoTherapy allows for differential dosing of multiple targets resulting in very elegant dose distributions. By its conformal nature, IMRT is very sensitive to improper patient setup. The use of pretreatment megavoltage CT (MVCT) imaging with helical TomoTherapy allows for increased precision with respect to patient positioning and use of a reduced planning target volume (PTV) margin."

They also reported finding the technique very reproducible.

For more information: http://muhc.ca, www.tomotherapy.com and http://www.ncbi.nlm.nih.gov/pubmed/20231076

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...